PEStore

Buyout PE

Divergent Investments

Divergent Investments acquires controlling stakes in established, profitable businesses, from United Kingdom. It states a focus on healthcare & life sciences.

Capital raised$56macross 1 SEC-filed vehicle
Most recent fund2021
HeadquartersUnited Kingdom
Largest single fund$56m

SEC filings

What Divergent Investments has raised

From this firm's own Form D filings. A fund files one within fifteen days of its first sale, under penalty of perjury, which makes these the hardest numbers on the page.

Vehicles filed1
Total capital raised$56m
Largest single vehicle$56m
Filing history2021
Smallest accepted commitmentNone stated
Filed fromLUXEMBOURG

Form D covers US-domiciled vehicles raised from accredited investors. It will not capture a fund raised outside the United States, separately managed accounts, or capital deployed off balance sheet, so treat these as a floor rather than a total.

Regulatory record

How Divergent Investments is registered

Registered with the SEC as an investment adviser, and incorporated in the United Kingdom.

Adviser statusExempt reporting adviser
Regulatory assets under managementNot reported by an ERA
Private funds advised3 · $31m gross
SEC adviser numberCRD 327211
Companies House number14495727
Incorporated2022-11-21
Register statusActive - Proposal to Strike off
Officers on the register1

An exempt reporting adviser is not required to report regulatory assets under management, so the blank above means the question was not asked rather than that the answer is unknown. Where a figure exists it is the gross asset value of the private funds the firm advises, which is a different and usually larger measure.

Portfolio

Disclosed holdings

Companies Divergent Investments lists on its own website. 1 carry a stated investment year.

CompanyInvestedYears heldRecorded transaction
Professional Triathletes Organization20224

Compiled from Divergent Investments’s published portfolio page. Where a recorded transaction is shown, that company was the target of a reported deal and has most likely already been realised. Nothing here is represented as being for sale.

Valuation context

Transaction values in Healthcare & Life Sciences

What companies have actually sold for in healthcare & life sciences, across 1,263 recorded transactions.

Median consideration$110m
Middle 50%$30m-$318m
Revenue multiple2.8×
EBITDA multiple12.5×

The full healthcare & life sciences picture - most active acquirers, recent transactions and every investor in the sector.

For owners

Own a healthcare & life sciences business?

The investors on this page acquire companies like yours. A confidential valuation costs nothing, commits you to nothing, and nobody is told you asked.

Request a confidential valuation

For investors

Is this Divergent Investments?

Claim this profile to correct anything wrong and tell us what you are looking for. We will send matching opportunities as they arise.

Claim or correct this profile

Targeted buyer search

Which hundred of these would actually buy your business?

A researched shortlist with a verified deal-team contact for each, and the reason it is on the list. Fixed fee, from $1,450 - or we make the approach for you and hand you the conversations.

See how it works

Comparable investors

Similar mandates

Other buyout pe investors active in healthcare & life sciences.